Weiss Asset Management LP[1 »

Gracell Biotechnologies shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 109k 10.04

More positions owned by Weiss Asset Management LP[1

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Splunk Note 1.125% 9/1 (Principal)
Theravance Biopharma (TBPH)
Cytokinetics Note 3.500% 7/0 (Principal)
Tesla Motors Call Option (TSLA)
American Airls Put Option (AAL)
Nextera Energy (NEE)
Vnet Group Note 2/0 (Principal)
Atmus Filtration Technologies Ord (ATMU)
Li Auto Note 0.250% 5/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
CRH Ord Put Option (CRH)
Coinbase Global Com Cl A Put Option (COIN)
NiSource (NI)

View all positions for Weiss Asset Management LP[1

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies